| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $62.7M | +124.0% |
| SG&A Expense | $20.9M | +53.0% |
| Operating Income | -$83.6M | -100.7% |
| Income Tax | $0 | — |
| Net Income | -$81.8M | -96.9% |
| EPS (Basic) | -$2.80 | -60.9% |
| EPS (Diluted) | -$2.80 | -60.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $111.9M | -23.2% |
| Short-term Investments | $1.1M | -95.9% |
| Current Assets | $117.8M | -33.3% |
| Total Assets | $129.3M | -30.4% |
| Current Liabilities | $19.1M | +311.9% |
| Total Liabilities | $20.8M | +200.0% |
| Stockholders' Equity | $108.5M | -39.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$62.4M | -76.1% |
| Capital Expenditures | $1.0M | -67.5% |
| Investing Cash Flow | $27.3M | +182.0% |
| Financing Cash Flow | $1.2M | -99.2% |
| Free Cash Flow | -$63.4M | -64.3% |